Brief: Labcorp Launches New Test To Identify And Confirm Neurodegenerative Disease
13/07/2022 13:15
July 13 (Reuters) - Laboratory Corporation of America
Holdings LH.N :
* LABCORP LAUNCHES NEW TEST TO IDENTIFY AND CONFIRM
NEURODEGENERATIVE DISEASE
Source text for Eikon: ID:nBw30RbDfa
Further company coverage: LH.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Laboratory of America Holdings
See all newsBrief: Labcorp To Announce Second Quarter 2026 Financial Results On July 30, 2026
Brief: Labcorp And Epic Expand Collaboration To Advance Diagnostic Integration Across Hospitals And Health Systems
U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, Avis
Labcorp lifts full‑year forecast as diagnostics business stays resilient (updated)
U.S. STOCKS ON THE MOVE-Qualcomm, Meta, Cardinal Health